EU stresses need for constant improvement in manufacturing
This article was originally published in Clinica
Executive Summary
If manufacturers do not apply stricter procedures in both the pre-market assessment and post-market surveillance of their medical devices, they risk manufacturing unsafe products that could land them in a litigious minefield. This was the warning delivered at the London Management Forum meeting on Safety Issues and Risk Management of Medical Devices on November 12.
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.